Related Experiment Video
Updated: Jan 20, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Congenital Heart Disease: Prenatal Diagnosis and Genetic Associations
Maeve K Hopkins1, Lorraine Dugoff2, Jeffrey A Kuller3
1Fellow, Division of Maternal Fetal Medicine.
Insights
Prenatal diagnosis of congenital heart disease (CHD) warrants genetic counseling and testing. Identifying genetic syndromes associated with CHD improves outcomes for newborns.
Area of Science:
- Genetics
- Neonatal Medicine
- Prenatal Diagnosis
Background:
- Congenital heart disease (CHD) is a significant cause of infant illness and death.
- Genetic abnormalities are frequently implicated in congenital cardiac defects.
- Early prenatal diagnosis of CHD is crucial for optimizing neonatal care.
Purpose of the Study:
- To outline appropriate prenatal genetic testing strategies for fetuses with congenital cardiac defects.
- To identify specific cardiac defects linked to fetal aneuploidy and genetic syndromes.
Main Methods:
- A comprehensive literature search was conducted using MEDLINE.
- Keywords included "genetic testing," "microarray," and "congenital heart disease."
- The review incorporated various evidence types, including peer-reviewed articles, systematic reviews, and expert opinions.
Main Results:
- The review synthesizes evidence from diverse sources to inform genetic testing recommendations.
- Specific congenital cardiac defects associated with genetic abnormalities were identified.
- The importance of integrating genetic findings into prenatal care was highlighted.
Conclusions:
- Referral for genetic counseling and testing is recommended upon prenatal detection of CHD.
- Prenatal identification of genetic syndromes associated with CHD is vital.
- Effective communication among obstetric, genetic, and pediatric specialists enhances maternal and infant outcomes.
Importance:
Congenital heart disease (CHD) is a common cause of neonatal morbidity and mortality. Several genetic abnormalities have been linked to congenital cardiac disease. When diagnosed prenatally, appropriate evaluation can help optimize neonatal outcomes.
Objective:
The objective of this review is to identify appropriate prenatal genetic testing when congenital cardiac defects are identified antenatally. This review also identifies specific congenital cardiac defects that are associated with fetal aneuploidy and genetic syndromes.
Evidence Acquisition:
A MEDLINE search of "genetic testing" or "microarray" and "congenital heart disease" and specific conditions reported in the review was performed.
Results:
The evidence cited in this review includes case reports or case series (4) textbooks (3), systematic reviews (1), expert committee opinions (10), and 37 additional peer-reviewed journal articles that were original research or expert summaries.
Conclusions And Relevance:
When CHD is identified through prenatal screening, patients should be referred for genetic counseling and offered appropriate genetic testing. Prenatal diagnosis of genetic syndromes related to CHD and close communication between obstetric, genetic, and pediatric providers can help optimize outcomes for both mother and baby.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
What is Genetic Engineering?
Animal Mitochondrial Genetics

